118 related articles for article (PubMed ID: 6271956)
1. The use of ascorbate as a probe of opioid receptor structure: evidence for two independent mechanisms of receptor destruction by ascorbate.
Cox BM; Leslie FM; Dunlap CE
J Recept Res; 1980; 1(2):329-54. PubMed ID: 6271956
[TBL] [Abstract][Full Text] [Related]
2. Dual effects of ascorbate on serotonin and spiperone binding in rat cortical membranes.
Muakkassah-Kelly SF; Andresen JW; Shih JC; Hochstein P
J Neurochem; 1983 Nov; 41(5):1429-39. PubMed ID: 6413657
[TBL] [Abstract][Full Text] [Related]
3. Ascorbate destruction of opiate stereospecific binding in guinea pig brain homogenate.
Dunlap CE; Leslie FM; Rado M; Cox BM
Mol Pharmacol; 1979 Jul; 16(1):105-19. PubMed ID: 39241
[No Abstract] [Full Text] [Related]
4. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
Chan B; Seeman P; Davis A; Madras BK
Eur J Pharmacol; 1982 Jun; 81(1):111-6. PubMed ID: 6126367
[TBL] [Abstract][Full Text] [Related]
5. Ascorbate induced lipid peroxidation results in loss of receptor binding in tris, but not in phosphate, buffer. Implications for the involvement of metal ions.
Abe K; Kogure K; Arai H; Nakano M
Biochem Int; 1985 Sep; 11(3):341-8. PubMed ID: 3933512
[TBL] [Abstract][Full Text] [Related]
6. Effects of radioligand oxidation and ascorbate-induced lipid peroxidation on serotonin-1 receptor assay: use of ascorbate and ethylenediamine tetraacetic acid buffers to prevent (3H)-5-HT binding artifacts.
May PC; Morgan DG; Salo D; Goss JR; Finch CE
J Neurosci Res; 1988; 20(2):257-62. PubMed ID: 3139891
[TBL] [Abstract][Full Text] [Related]
7. Ascorbate-induced lipid peroxidation and inhibition of [3H]spiroperidol binding in neostriatal membrane preparations.
Heikkila RE; Cabbat FS
J Neurochem; 1983 Nov; 41(5):1384-92. PubMed ID: 6619873
[TBL] [Abstract][Full Text] [Related]
8. Ascorbate-induced lipid peroxidation and the binding of [3H]dihydroalprenolol.
Heikkila RE
Eur J Pharmacol; 1983 Sep; 93(1-2):79-85. PubMed ID: 6628548
[TBL] [Abstract][Full Text] [Related]
9. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
10. Ascorbate inhibits specific binding of etorphine and low Km GTPase in NG108-15 hybrid cells.
Bhatia M; Ralhan R; Sharma SK
Indian J Biochem Biophys; 1988 Dec; 25(6):699-702. PubMed ID: 2855630
[No Abstract] [Full Text] [Related]
11. Ascorbate/Fe(3+)-induced peroxidation and inhibition of the binding of A1 adenosine receptor ligands in rat brain membranes.
Oliveira JC; Constantino MD; Sebastião AM; Ribeiro JA
Neurochem Int; 1995 Mar; 26(3):263-8. PubMed ID: 7787774
[TBL] [Abstract][Full Text] [Related]
12. Effect of ascorbate on the toxicity of morphine in mice.
Dunlap CE; Leslie FM
Neuropharmacology; 1985 Aug; 24(8):797-804. PubMed ID: 3018618
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of ascorbic acid on the binding of [3H]dopamine antagonists to neostriatal membrane preparations: relationship to lipid peroxidation.
Heikkila RE; Cabbat FS; Manzino L
J Neurochem; 1982 Apr; 38(4):1000-6. PubMed ID: 7062025
[TBL] [Abstract][Full Text] [Related]
14. Ascorbate decreases ligand binding to neurotransmitter receptors.
Leslie FM; Dunlap CE; Cox BM
J Neurochem; 1980 Jan; 34(1):219-21. PubMed ID: 6256473
[No Abstract] [Full Text] [Related]
15. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.
Su TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):284-90. PubMed ID: 6290634
[TBL] [Abstract][Full Text] [Related]
16. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
17. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
Scheuhammer AM; Cherian MG
Biochem Pharmacol; 1985 Oct; 34(19):3405-13. PubMed ID: 3931643
[TBL] [Abstract][Full Text] [Related]
18. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
[TBL] [Abstract][Full Text] [Related]
19. Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes.
Demoliou-Mason CD; Barnard EA
J Neurochem; 1986 Apr; 46(4):1118-28. PubMed ID: 3005504
[TBL] [Abstract][Full Text] [Related]
20. Divalent cations: do they stabilize the agonist (12S) form of the mu opioid receptor?
Jauzac P; Frances B; Puget A; Meunier JC
Neuropeptides; 1984 Dec; 5(1-3):125-8. PubMed ID: 6099479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
